Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls

Journal of the American Academy of Dermatology

Volumn 47, Issue 1, 2002, Pages 28-32

  Neisius, Ulrich ^a   Olsson, Richard ^a   Rukwied, Roman ^a   Lischetzki, Grischa ^a   Schmelz, Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN; PROSTAGLANDIN E2;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LASER DOPPLER FLOWMETRY; MALE; MICRODIALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN SECRETION; PRURITUS; PSYCHOPHYSIOLOGY; SKIN BLOOD FLOW; TIME SERIES ANALYSIS; VASODILATATION; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SKIN;

ADULT; ANALYSIS OF VARIANCE; DERMATITIS, ATOPIC; DINOPROSTONE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; MALE; MICRODIALYSIS; PROBABILITY; PRURITUS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SKIN; VASODILATION;

EID: 0036628537     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120462     Document Type: Article

References (36)

1. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999;135:1522-5.
2. Woodward DF, Nieves AL, Hawley SB, Joseph R, Merlino GF, Spada CS. The pruritogenic and inflammatory effects of prostanoids in the conjunctiva. J Ocul Pharmacol Ther 1995;11:339-47.
3. Greaves MW, McDonald-Gibson W. Itch: role of prostaglandins. Br Med J 1973;3:608-9.
4. Hägermark O, Strandberg K, Hamberg M. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog. J Invest Dermatol 1977;69:527-30.
5. Yosipovitch G, Ademola J, Lui P, Amin S, Maibach HI. Topically applied aspirin rapidly decreases histamine induced itch. Acta Derm Venereol (Stockh) 1997;77:46-8.
6. Woodward DF, Nieves AL, Friedlaender MH. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. J Pharmacol Exp Ther 1996;279:137-42.
7. Daly BM, Shuster S. Effect of aspirin on pruritus [abstract]. Br Med J (Clin Res Ed) 1986;293:907.
8. Hägermark O. Influence of antihistamines, sedatives, and aspirin on experimental itch. Acta Derm Venereol 1973;53:363-8.
9. Fjellner B, Hägermark O. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol 1979;59:505-12.
10. Nilsson HJ, Levinsson A, Schouenborg J. Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain 1997; 71:49-55.
11. Atanassoff PG, Brull SJ, Zhang J, Greenquist K, Silverman DG, LaMotte RH. Enhancement of experimental pruritus and mechanically evoked dysesthesiae with local anesthesia. Somatosens Mot Res 1999;16:291-8.
12. Petersen LJ, Nielsen HJ, Skov PS. Codeine induced histamine release in intact human skin monitored by skin microdialysis technique comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy 1995;25:1045-52.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-7.
14. Diepgen TL, Fartasch M, Hornstein OP. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population. Acta Derm Venereol Suppl (Stockh) 1989:144:50-4.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
16. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-5.
17. Ruzicka T, Simmet T, Peskar BA, Ring J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986;86:105-8.
18. Herbert MK, Tafler R, Schmidt RF, Weis KH. Cyclooxygenase inhibitors acetylsalicylic acid and indomethacin do not affect capsaicin-induced neurogenic inflammation in human skin. Agents Actions 1993;38 Spec No:C25-7.
19. Schmelz M, Kress M. Topical acetylsalicylate attenuates capsaicin induced pain, flare, and allodynia but not thermal hyperalgesia. Neurosci Lett 1996;214:72-4.
20. Schmelz M, Weber S, Kress M. Topical acetyl salicylate and dipyrone attenuate neurogenic protein extravasation in rat skin in vivo. Neurosci Lett 2000;290:57-60.
21. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE. Specific C-receptors for itch in human skin. J Neurosci 1997;17: 8003-8.
22. Andrew D, Craig AD. Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001;4:72-7.
23. Schmelz M. A neural pathway for itch. Nat Neurosci 2001;4:9-10.
24. Schmelz M, Schmidt R, Weidner C, Torebjörk HE, Handwerker HO. Chemical responsiveness of mechanosensitive and -insensitive C nociceptors in human skin. Soc Neurosci Abstr 1998;24:383.
25. Klemp P, Staberg B. Cutaneous blood flow during white dermographism in patients with atopic dermatitis. J Invest Dermatol 1982;79:243-5.
26. Hornstein OP, Heyer G, Langenstein B. Studies on dermographometry in atopic eczema. Acta Derm Venereol Suppl (Stockh) 1989;144:146-8.
27. Juhlin L, Michaelsson G. Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol 1969;49:251-61.
28. Sabroe RA, Kennedy CT, Archer CB. The effects of topical doxepin on responses to histamine, substance P, and prostaglandin E2 in human skin. BrJ Dermatol 1997;137:386-90.
29. Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, et al. Acute effects of SP and CGRP in human skin: a microdialysis study. J Invest Dermatol 2000;115:1015-20.
30. Kingston WP, Greaves MW. Actions of prostaglandin E2 metabolites on skin microcirculation. Agents Actions 1985;16:13-4.
31. Sciberras DG, Goldenberg MM, Bolognese JA, James I, Baber NS. Inflammatory responses to intradermal injection of platelet activating factor, histamine, and prostaglandin E2 in healthy volunteers: a double blind investigation. Br J Clin Pharmacol 1987; 24:753-61.
32. Chan CC, Ford-Hutchinson A. Effects of synthetic leukotrienes on local blood flow and vascular permeability in porcine skin. J Invest Dermatol 1985;84:154-7.
33. Mills PC, Ng JC, Seawright AA, Auer DE. Vascular leakage induced by histamine, bradykinin, serotonin, and prostaglandin E2 in greyhounds. Aust Vet J 1993;70:21-4.
34. Morley J, Page CP, Paul W. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Br J Pharmacol 1983;80:503-9.
35. Johnston MG, Hay JB, Movat HZ. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia). Agents Actions 1976;6:705-11.
36. Brain SD, Williams TJ. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 1985; 86:855-60.